Post-Implantation Syndrome and Laboratory Markers Following EVAR and TEVAR

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

April 15, 2025

Conditions
Postimplantation SyndromeEndovascular Abdominal Aortic Aneurysm Repair (EVAR)Thoracic Endovascular Aortic Repair
Interventions
PROCEDURE

Endovascular Aortic Intervention

This intervention involves EVAR or TEVAR for the treatment of abdominal or thoracic aortic aneurysms, respectively. The procedures were performed using commercially available stent-grafts via a transfemoral approach under standard perioperative protocols. The study specifically focuses on the systemic inflammatory response following these interventions, with close monitoring of laboratory parameters including IL-6, neutrophil-to-lymphocyte ratio (NLR), CRP, leukocyte count, and procalcitonin during the early postoperative period. No adjunctive anti-inflammatory or immunomodulatory therapies were administered.

Trial Locations (3)

25025

Atatürk University, Erzurum

25100

Atatürk University, Erzurum

25240

Ataturk University, Erzurum

All Listed Sponsors
lead

Ataturk University

OTHER

NCT07014839 - Post-Implantation Syndrome and Laboratory Markers Following EVAR and TEVAR | Biotech Hunter | Biotech Hunter